These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 24044518)

  • 21. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients.
    Ganame J; Claus P; Uyttebroeck A; Renard M; D'hooge J; Bijnens B; Sutherland GR; Eyskens B; Mertens L
    J Am Soc Echocardiogr; 2007 Dec; 20(12):1351-8. PubMed ID: 17604960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines.
    Coutinho Cruz M; Moura Branco L; Portugal G; Galrinho A; Timóteo AT; Rio P; Ilhão Moreira R; Mendonça T; Leal A; Gameiro F; Duarte Oliveira S; Luz R; Cruz Ferreira R
    Clin Res Cardiol; 2020 Jun; 109(6):673-684. PubMed ID: 31559482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer.
    Yu AF; Raikhelkar J; Zabor EC; Tonorezos ES; Moskowitz CS; Adsuar R; Mara E; Huie K; Oeffinger KC; Steingart RM; Liu JE
    Biomed Res Int; 2016; 2016():9363951. PubMed ID: 26942202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echocardiographic Assessment of Cardiotoxic Effects of Cancer Therapy.
    Bottinor WJ; Migliore CK; Lenneman CA; Stoddard MF
    Curr Cardiol Rep; 2016 Oct; 18(10):99. PubMed ID: 27566332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up.
    Elitok A; Oz F; Cizgici AY; Kilic L; Ciftci R; Sen F; Bugra Z; Mercanoglu F; Oncul A; Oflaz H
    Cardiol J; 2014; 21(5):509-15. PubMed ID: 24142687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study.
    Boyd A; Stoodley P; Richards D; Hui R; Harnett P; Vo K; Marwick T; Thomas L
    PLoS One; 2017; 12(4):e0175544. PubMed ID: 28407011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of long-term cardiac side effects of anthracycline chemotherapy by conventional and non-conventional echocardiographic methods in childhood cancer survivors.
    Yoldaş T; Yeşil Ş; Karademir S; Şahin G; Arman Örün U; Doğan V; Özgür S
    Cardiol Young; 2019 Jul; 29(7):904-909. PubMed ID: 31218970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Clarke JL; Thomas L
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):228-34. PubMed ID: 22782955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility.
    Santoro C; Arpino G; Esposito R; Lembo M; Paciolla I; Cardalesi C; de Simone G; Trimarco B; De Placido S; Galderisi M
    Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):930-936. PubMed ID: 28379383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction.
    Poterucha JT; Kutty S; Lindquist RK; Li L; Eidem BW
    J Am Soc Echocardiogr; 2012 Jul; 25(7):733-40. PubMed ID: 22578518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anthracycline induced inconsistent left ventricular segmental systolic function variation in patients with lymphoma detected by three-dimensional speckle tracking imaging.
    Xu Y; Shi J; Zhao R; Zhang C; He Y; Lin J; Zhang Q; Shu X; Cheng L
    Int J Cardiovasc Imaging; 2019 May; 35(5):771-779. PubMed ID: 30684081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline.
    Sung RY; Huang GY; Shing MK; Oppenheimer SJ; Li CK; Li CK; Lau J; Yuen MP
    Int J Cardiol; 1997 Aug; 60(3):239-48. PubMed ID: 9261634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redefining anthracycline-related subclinical cardiotoxicity: 'Absolute' and 'relative' change in longitudinal strain.
    Terluk A; Stefani L; Boyd A; Vo K; Byth K; Hui R; Richards D; Thomas L
    ESC Heart Fail; 2024 Oct; 11(5):3210-3221. PubMed ID: 38887181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical reduction in left ventricular function using triplane and 2D speckle tracking echocardiography after anthracycline exposure in children.
    Çilsal E; Oğuz AD; Tunaoğlu FS; Kula S; Pektaş A
    Anatol J Cardiol; 2018 Jan; 19(1):58-66. PubMed ID: 29339701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
    Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
    Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical ventricular dysfunction detected by speckle tracking two years after use of anthracycline.
    de Almeida AL; Silva VA; de Souza Filho AT; Rios VG; Lopes JR; de Afonseca SO; Cunha Dde C; Mendes MO; Miranda DL; dos Santos Júnior EG
    Arq Bras Cardiol; 2015 Apr; 104(4):274-83. PubMed ID: 25993590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance.
    Jordan JH; D'Agostino RB; Hamilton CA; Vasu S; Hall ME; Kitzman DW; Thohan V; Lawrence JA; Ellis LR; Lash TL; Hundley WG
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):872-9. PubMed ID: 25273568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
    Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
    Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up.
    Elbl L; Hrstkova H; Tomaskova I; Michalek J
    Support Care Cancer; 2006 Feb; 14(2):128-36. PubMed ID: 16034614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection of left ventricular contractility abnormalities by two-dimensional speckle tracking strain in Chagas’ disease.
    Barbosa MM; Costa Rocha MO; Vidigal DF; Bicalho Carneiro Rde C; Araújo RD; Palma MC; Lins de Barros MV; Nunes MC
    Echocardiography; 2014 May; 31(5):623-30. PubMed ID: 25232573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.